Robert Hoffman is Professor at Ohio State University. OpenAlex indexes 151 publications with 4,700 citations (h-index 29); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 28 Oct 2026
Overview
Updated 31 Oct 2026
Robert Hoffman, MD, is Professor at Ohio State University. The public record shows 151 publications with 4,700 citations (h-index 29), centered on Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes and associated disorders. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 1 companies, 3 NIH-funded awards (2004–2025).
- Most recent indexed publication: 2026 · Journal of pediatric endocrinology & metabolism
- Top research focus: Diabetes Management and Research
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 31 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 71.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Sponsor: George Washington University
- CASH- Children Active to Stay Healthy
Sponsor: Nationwide Children's Hospital
- Measurement Of Endotracheal Tube Cuff Pressure In Emergency Department Patients
Sponsor: Beth Israel Medical Center
Industry payments
Updated 31 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
100%l-Thyroxine100%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 31 Oct 2026
3 NIH research awards on record, funded 2004–2025 per NIH RePORTER. The latest:
- Identify risk factors for type 2 diabetes in adolescents
Research Inst Nationwide Children'S Hosp
FY2025$684,083U01DK135015 - Identify risk factors for type 2 diabetes in adolescents
Research Inst Nationwide Children'S Hosp
FY2024$776,588U01DK135015 - Identify risk factors for type 2 diabetes in adolescents
Research Inst Nationwide Children'S Hosp
FY2023$57,952U01DK135015
Congress activity
Updated 31 Oct 2026
11 congress contributions (2018–2024) across ADA, ENDO per OpenAlex. The most recent:
- 1187-P: Increased C4B Gene Copy Number Is Associated with Increased Inflammation in Adolescent Type 1 Diabetes
ADA Scientific Sessions
ADA2024Co-authorPoster - 7970 C3 and C4 Levels Decrease Post-prandial in Adolescents with type 1 Diabetes
ENDO Annual Meeting
ENDO2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 31 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The prevalence of autoimmune diseases in antibody negative type 1 diabetes mellitus.
Journal of pediatric endocrinology & metabolism
Article2026 - Diabetes distress, depression, and future glycemic control among adolescents with type 1 diabetes.
Journal of pediatric endocrinology & metabolism
Article2025 - Autosomally dominantly inherited isolated gonadotropin deficiency via maternal assisted reproduction due to SOX10 mutation.
Journal of pediatric endocrinology & metabolism
Case Report2025 - Hematologic and biochemical inflammatory markers increase with body mass and positively correlate in adolescents.
Pediatric research
Article2024
Most-cited works
by citation count (OpenAlex)- 01Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.Article1,075 citations1991
- 02
- 03Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.Article221 citations1992
- 04The complement system and human autoimmune diseasesReview182 citations2022
- 05Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United StatesArticle182 citations2015
Network
Updated 31 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 31 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
applykite.com/professors/robert-hoffman-0a4587a4-1c7e-44a8-8dbb-dcb1edb2b7d2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →applykite.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acpeds.org ↗
Editorial & leadership roles
journal and society appointments- Study Chair
Growth Hormone and Endothelial Function in Children (NCT00373386)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinicaltrials.gov ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acpeds.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH